Deliverx Pharma宣布反向股票分拆;股价下跌

2025-01-24 05:11

Vincerx Pharma (NASDAQ:VINC) said on Thursday that its board has approved a 1-for-20 reverse stock split of its issued shares of common stock, which will be effective as of January 27, 2025.
Vincerx’s common stock will continue trading on The Nasdaq Stock Market under the existing symbol VINC and will begin trading on a split-adjusted basis when the market opens on January 28, 2025, with a new CUSIP number.
As of the effective time of the reverse stock split, every twenty issued shares of Vincerx’s common stock will be combined, reclassified and converted into one issued share of Vincerx’s common stock.
This will reduce the number of shares issued from approximately 44.8 million shares to approximately 2.2 million shares, subject to adjustment for fractional shares.
Vincerx Pharma (VINC) shares were down more than 16% in post-market trading.

More on Vincerx Pharma